A new study from Tel Aviv University (TAU) found a promising treatment for long-term COVID-19 symptoms based on advanced Hyperbaric Oxygen Therapy (HBOT). The study is the first randomized controlled trial to demonstrate a real solution for long COVID. Patients exposed to an intensive protocol of HBOT treatments showed significant improvement compared to a control… Read More
A new study by Tel Aviv University (TAU) and Ben Gurion University of the Negev, in collaboration with the Israeli Ministry of Health, has found that a fourth dose of the existing COVID-19 vaccine is effective in protecting the elderly population in long-term care facilities from the Omicron variant. The research was based on a… Read More
A new Tel Aviv University (TAU) study reveals that many SARS-CoV-2 variants are likely formed in chronic COVID-19 patients who suffer from immunosuppression. The researchers suggest that a weakened antibody response, particular in the lower airways of these chronic patients, may prevent full recovery from the virus and drive the virus to mutate many times… Read More
A new study from Tel Aviv University (TAU) enables vaccine developers to determine vaccine safety via smart wearable sensors that measure objective physiological parameters. According to the researchers, most clinical trials testing the safety of new vaccines. including COVID-19 vaccines, rely on participants’ subjective reports, which can lead to biased results. In contrast, objective physiological… Read More
Experts from Tel Aviv University (TAU) have shown that a new combination of common dietary supplements can provide protection against the COVID-19 virus as well as several common winter illnesses. The study was led by Professor Ehud Gazit, Professor Eran Bacharach, and Professor Daniel Segal of the Shmunis School of Biomedicine and Cancer Research at… Read More
TAU Professor Jonathan Gershoni tells the story of the significant scientific landmarks that led to the creation of RNA vaccines, that are significant in the global battle against the pandemic.
A team of experts led by Tel Aviv University (TAU) has identified five of the 29 proteins in the coronavirus that are responsible for damaging blood vessels. The researchers hope that the identification of these proteins will help develop targeted drugs for COVID-19 that reduce vascular damage. The study was led by Dr. Ben Maoz… Read More
A joint study conducted by researchers from Tel Aviv University (TAU) and the Shamir Medical Center (Asaf Harofe) indicates that the level of COVID-19 antibodies in the human blood stream differs according to age groups, gender, symptoms, and time elapsed since vaccination. The research examined the level of antibodies in over 26,000 blood samples taken… Read More